Crossmark

Obscure DNA sequences unveil a new cancer target

Crossref DOI link: https://doi.org/10.1038/s41594-024-01347-x

Published Online: 2024-07-08

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sfeir, Agnel http://orcid.org/0000-0003-1633-8535
License Information

Text and Data Mining valid from 2024-07-08

Version of Record valid from 2024-07-08
More Information

Article History

First Online: 8 July 2024

Competing interests

: A.S. is a co-founder, shareholder and consultant for Repare Therapeutics.